3-5
2026
影响因子区间
51天
平台估算
42%
2025
中国作者发文占比
—
收费
期刊简介:The Official Journal of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)Clinica Chimica Acta is a high-quality journal which publishes original Research Communications in the field of clinical chemistry and laboratory medicine, defined as the diagnostic application of chemistry, biochemistry, immunochemistry, biochemical aspects of hematology, toxicology, and molecular biology to the study of human disease in body fluids and cells.The objective of the journal is to publish novel information leading to a better understanding of biological mechanisms of human diseases, their prevention, diagnosis, and patient management. Reports of an applied clinical character are also welcome. Papers concerned with normal metabolic processes or with constituents of normal cells or body fluids, such as reports of experimental or clinical studies in animals, are only considered when they are clearly and directly relevant to human disease. Evaluation of commercial products have a low priority for publication, unless they are novel or represent a technological breakthrough. Studies dealing with effects of drugs and natural products and studies dealing with the redox status in various diseases are not within the journal's scope. Development and evaluation of novel analytical methodologies where applicable to diagnostic clinical chemistry and laboratory medicine, including point-of-care testing, and topics on laboratory management and informatics will also be considered. Studies focused on emerging diagnostic technologies and (big) data analysis procedures including digitalization, mobile Health, and artificial Intelligence applied to Laboratory Medicine are also of interest.
【译文】《国际临床化学和实验室医学联合会(IFCC)官方期刊》 Clinica Chimica Acta 是一本高质量的期刊,发表关于临床化学和实验室医学领域的原创研究通讯,定义为化学、生化、免疫化学、血液学的生化方面、毒理学和分子生物学在体液和细胞中研究人类疾病的应用诊断。该期刊的目标是发表新颖的信息,以更好地理解人类疾病的生物学机制、预防和诊断以及患者管理。欢迎发表具有应用临床特性的报告。有关正常代谢过程或正常细胞或体液的成分的报告,如动物实验或临床研究,只有在它们与人类疾病有明确和直接相关性时才会考虑。商业产品的评估在发表时优先级较低,除非它们是新颖的或代表技术突破。涉及药物和天然产物的影响以及涉及各种疾病中的氧化还原状态的研究不在该期刊的范围内。在适用的诊断临床化学和实验室医学领域,包括即时检测和实验室管理与信息学主题的开发和评估也将被考虑。专注于新兴诊断技术和(大数据)分析程序的研究,包括数字化、移动健康和人工智能在实验室医学中的应用,也很有兴趣。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q1 | 暂无 |
| 影响因子区间 | 3-5 | 暂无 |